Sentences with phrase «of phenylpropanolamine»

Ensures sustained phenylpropanolamine levels in the blood stream and may help reduce the conditions often associated with high levels of phenylpropanolamine such as: decreased appetite, changes in heart rate, increased blood pressure, hyperexcitability

If a dog owner notices any of these symptoms, she should discontinue the use of phenylpropanolamine and contact her veterinarian for further assistance.

Also, the use of phenylpropanolamine, a medication removed from the human market because of increased stroke risks, is still common in dogs as treatment for urinary incontinence.

Not exact matches

Consult a Physician before using this product if you have, or have a family history of, including but not limited to Phenylketonuria, high blood pressure, cardiac arrhythmias, heart, liver, kidney, thyroid, or psychiatric disease, pheochromocytoma, diabetes, asthma, recurrent headaches, anemia, nervousness, anxiety, depression or other psychiatric condition, peptic ulcers, Parkinson's disease, glaucoma, difficulty in urinating, prostate enlargement, or seizure disorder, or if you are using any other dietary supplement or over-the-counter drug containing ephedrine, pseudo - ephedrine, or phenylpropanolamine (ingredients found in certain allergy, asthma, cough or cold, and weight control products).

Most products of this type have ingredients such as caffeine, ephedrine, and phenylpropanolamine.

One case study found that when a patient submitted to the ER ingested a commercially available diet pills containing the appetite suppressant phenylpropanolamine, the inhibition of prostaglandins caused by the drug resulted in extreme hypertension (19).

However, because of the small risk of hormonal side effects, another drug called phenylpropanolamine or Proin replaced DES as the most common drug of choice in treating incontinent pets.

In one study of dogs that had failed on medication, there was complete resolution of incontinence in 53 % with colposuspension An additional 37 % became less incontinent, and 25 % of those without full resolution gained complete continence when therapy with phenylpropanolamine was added.

Answer: Proin, active ingredient phenylpropanolamine, usually works the best with the least amount of side effects.

Washington: The U.S. Food and Drug Administration (FDA) isn't advertising it, but veterinarians can buy phenylpropanolamine (PPA) despite a government - proposed ban of the drug and a recent dry spell in its manufacture.

General Description: Phenylpropanolamine is used in dogs for long - term management of urinary incontinence conditions.

This is just a summary of information about phenylpropanolamine.

Phenylpropanolamine should not be used within 2 weeks of their use.

The side effects of Prion (Phenylpropanolamine) are irritability, increased heart rate, increased blood pressure, and loss of appetite; Ptyalism isn't listed as a side effect.

Because of its effects in elevating heart rate and blood pressure, phenylpropanolamine should not be used in patients with heart disease or pre-existing high blood pressure.

An increased risk of hypertension can also occur if phenylpropanolamine is given in conjunction with tricyclic antidepressants (such as amitriptyline), non-steroidal anti-inflammatory drugs (NSAIDs), or amitraz (active ingredient of several tick control products).

A number of drugs, including aspirin and tricyclic antidepressants, can cause side effects on their own or increase the intensity of other side effects if they're used in conjunction with phenylpropanolamine.

Concurrent use of Anipryl ® with ephedrine, phenylpropanolamine, other MAO inhibitors such as amitraz, meperidine, or other opioids, and tricyclic antidepressants, tetracyclic antidepressants, or selective serotonin reuptake inhibitors is not recommended.

Representation of leading pharmaceutical manufacturers in various substantial cases involving, among others, the following drugs: phen / fen diet drugs, OxyContin and phenylpropanolamine (PPA);

Litig., MDL No. 1708, and served on the discovery committee of In re Phenylpropanolamine («PPA») Products Liab.